Pulmonary Hemodynamics During Exercise - Research Network
NCT ID: NCT03954574
Last Updated: 2025-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1500 participants
OBSERVATIONAL
2018-12-01
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Physical Training on Vascular Function as a Therapeutic Target in Pulmonary Hypertension
NCT03550729
Exercise Hemodynamic, Right Ventricular Coupling and Echocardiography in Pulmonary Hypertension
NCT04663217
Influence of Respiratory and Exercise Therapy on Oxygen Uptake, Quality of Life and Right Ventricular Function in Severe Pulmonary Hypertension
NCT01394367
Exercise Intervention in Patients With Heart Failure With Preserved and Reduced Ejection Fraction
NCT05255172
Effect of mechanIcal circulatoRy Support ON Exercise Capacity aMong pAtieNts With Heart Failure
NCT03078972
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Retrospective patient cohort
assessment of pulmonary hemodynamics during exercise by right heart catheterization
all patients undergo right heart catheterization during exercise due to clinical reasons. Results of this and other Routine clinical tests will be included in the registry
Prospective patient cohort
assessment of pulmonary hemodynamics during exercise by right heart catheterization
all patients undergo right heart catheterization during exercise due to clinical reasons. Results of this and other Routine clinical tests will be included in the registry
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
assessment of pulmonary hemodynamics during exercise by right heart catheterization
all patients undergo right heart catheterization during exercise due to clinical reasons. Results of this and other Routine clinical tests will be included in the registry
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent of participating subjects after being fully briefed (for prospective analysis)
Exclusion Criteria
* Patients without sufficient follow-up data (information on survival / lung transplantation)
* advanced tumour disease or other diseases with a short life expectancy, except pulmonary vascular diseases
* advanced heart failure with pulmonary arterial wedge pressure (PAWP) \> 18 mmHg at rest
* uncontrolled systemic arterial hypertension (RR values \> 160/100 mmHg at rest)
* FEV1\<50% predicted
* TLC\<60% predicted
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Respiratory Society
OTHER
Medical University of Graz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Horst Olschewski, MD
Role: STUDY_CHAIR
Medical University of Graz
Philippe Herve, MD
Role: STUDY_CHAIR
Centre Chirugical Marie Lannelongue
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arizona, Banner University Medical Center
Phoenix, Arizona, United States
University of California, Los Angeles, Lung & Heart-Lung Transplant and Pulmonary Hypertension Programs, David Geffen School of Medicine
Los Angeles, California, United States
Johns Hopkins Hospital, Advanced HF, MCS, Transplant Cardiology, Baltimore, Maryland, USA
Baltimore, Maryland, United States
Massachusetts General Hospital, Cardiology Division and Pulmonary Unit
Boston, Massachusetts, United States
Harvard Medical School, Brigham and Women's Hospital
Boston, Massachusetts, United States
University of Minnesota Medical School, Division of Cardiology, Department of Medicine, Lillehei Heart Institute Minneapolis, Minnesota, USA
Minneapolis, Minnesota, United States
Mayo Clinic, Division of Cardiovascular Diseases, Department of Medicine
Rochester, Minnesota, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Royal Prince Alfred Hospital, Respiratory Medicine
Camperdown, , Australia
Medical University of Graz
Graz, , Austria
Free University of Brussels, Faculty of Medicine, Physiology
Brussels, , Belgium
University of São Paulo Medical School
São Paulo, , Brazil
Department of Cardiology, Aarhus University Hospital, Denmark
Aarhus, , Denmark
Université de Lorraine
Nancy, , France
Centre Chirurgical Marie Lannelongue, Thoracic and Vascular Surgery
Paris, , France
Centre de Référence de l'Hypertension Pulmonaire, Université ParisSud - Université Paris-Saclay, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris
Paris, , France
Sorbonne Universités, Neurophysiologie respiratoire expérimentale et clinique
Paris, , France
University of Cologne, Klinik III fuer Innere Medizin
Cologne, , Germany
Justus-Liebig-University Giessen, Department of Internal Medicine
Giessen, , Germany
University of Greifswald
Greifswald, , Germany
Thorax Clinic Heidelberg, Centre for Pulmonary Hypertension
Heidelberg, , Germany
Academic Teaching Hospital of the Julius Maximilian University of Würzburg
Würzburg, , Germany
University of Bologna
Bologna, , Italy
University of Rome La Sapienza, Cardiovascular and Respiratory Sciences
Roma, , Italy
VU Medisch Centrum, Pulmonology
Amsterdam, , Netherlands
Otwock Medical Center of Postgraduate Education, Department of Pulmonary Circulation and Thromboembolic Diseases
Otwock, , Poland
Barcelona Hospital Clínic, Pneumologia
Barcelona, , Spain
University Hospital of Zurich, Internal Medicine
Zurich, , Switzerland
Scottish Pulmonary Vascular Unit
Glasgow, , United Kingdom
Imperial College, NHS Healthcare NHS Trust, National Pulmonary Hypertension Service
London, , United Kingdom
Royal Brompton Hospital
London, , United Kingdom
Royal Hallamshire Hospital, Sheffield Pulmonary Vascular Disease Unit
Sheffield, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
30-437 ex 17/18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.